Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT02918032

International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV)…

This study aims to understand the state of onset of NLSD(neutral lipid storage disease) / TGCV(triglyceride deposit cardiovasculopathy) worldwide, background in…

United States, Austria +2 more120 participantsStarted 2014-01

All recent trials (3 shown)

CompletedNot Applicable

NCT05345223

A Registry Study on Primary/idiopathic Triglyceride Deposit Cardiomyovasculopathy

The objective of this study is to construct a registry; in order to understand the onset status of triglyceride deposit cardiomyovasculopathy (TGCV) in Japan wi…

Japan193 participantsStarted 2022-03-31

TerminatedNot Applicable

NCT02830763

Clinical Study on the Safety of CNT-02 for TGCV and NLSD-M

This study is planning to evaluate the safety and clinical efficacy of medium-chain fatty acid capsules (food-grade CNT-02) in subjects with primary triglycerid…

Italy, Japan2 participantsStarted 2016-09-05

Treatment: CNT-02